Application of Apamarga Ksharodak and Intralesional Cidofovir in the management of Charmakeela(Warts)
Phase 3
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2023/01/048654
- Lead Sponsor
- Datta Meghe Institute of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patient willing with written informed consent as per Helsinki declaration.
2. Age group of 17 to 70 years.
3. Patients with clinical features of warts of painless , small ,rough and hard growth similar to skin .
4. Patients irrespective of gender, occupation and economic status.
Exclusion Criteria
1. Uncontrolled and insulin dependent Diabetes Mellitus, Uncontrolled Hypertension , Tuberculosis, Carcinoma , Endocrine Disorders and Kidney or hepatic disorder.
2. Sites of warts â?? sensitive places like : genitals, eye lids, lips, etc .
3. History of anticoagulants and haemophilla.
4. Pregnant and lactating females.
5. Substantial abnormalities in hematological
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method First assesment will be of pain, Size of charmakeela.Timepoint: 1 week
- Secondary Outcome Measures
Name Time Method Secondary Assesment will be of Shed off day and Scar .Timepoint: 2 weeks